BGMS - Bio Green Med Solution, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 5.83 -0.62 (-10.63%) | --- | --- | 0.0 (0.0%) | -0.22 (-3.77%) | -0.57 (-10.12%) | 0.01 (0.19%) | 0.01 (0.19%) |
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 100.0
- VWAP:
- 5.21
- RVol:
- 0.3422
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 60m | Price increase 60m | 6.0 +0.38 (+6.73%) | Oct 15 09:31 |
| 1m | Price increase 1m | 5.85 +0.22 (+3.91%) | Oct 15 09:30 |
| 10m | Price increase 10m | 5.85 +0.22 (+3.91%) | Oct 15 09:30 |